Literature DB >> 17233534

Quantitative determination of total methamphetamine and active metabolites in rat tissue by liquid chromatography with tandem mass spectrometric detection.

Howard Hendrickson1, Elizabeth Laurenzana, S Michael Owens.   

Abstract

High-throughput liquid chromatography with tandem mass spectrometric detection (LC-MS/MS) methodology for the determination of methamphetamine (METH), amphetamine (AMP), 4-hydroxymethamphetamine (4-OH-METH), and 4-hydroxyamphetamine (4-OH-AMP) was developed and validated using simple trichloroacetic acid sample treatment. The method was validated in rat serum, brain, and testis. Lower limits-of-quantitation (LOQ) for METH and AMP were 1 ng x mL(-1) using positive ion electrospray tandem mass spectrometry (MS/MS). The accuracy of the method was within 25% of the actual values over a wide range of analyte concentrations. The within-assay precision was better than 12% (coefficient of variation). The method was linear over a wide dynamic range (0.3-1000 ng x mL(-1)). Quantitation was possible in all 3 matrices using only serum standards because of minimal matrix-associated ion effects or the use of an internal standard. Finally, the LC-MS/MS method was used to determine serum, brain, and testis METH and AMP concentrations during a subcutaneous infusion (5.6 mg kg(-1) day(-1)) of METH in rats. Concentrations of 4-OH-AMP and 4-OH-METH were below the LOQ in experimental samples. The bias introduced by using serum calibrators for the determination of METH and AMP concentrations in testis and brain was less than 8% and insignificant relative to the interanimal variability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17233534      PMCID: PMC2751367          DOI: 10.1208/aapsj080480

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  48 in total

1.  A novel on-line solid-phase extraction approach integrated with a monolithic column and tandem mass spectrometry for direct plasma analysis of multiple drugs and metabolites.

Authors:  Xu Zang; Rosa Luo; Ning Song; Ta Kung Chen; Haig Bozigian
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

2.  Sensitive liquid chromatography-tandem mass spectrometry method for the determination of scutellarin in human plasma: Application to a pharmacokinetic study.

Authors:  Shen Yulan; Feng Fang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-11-02       Impact factor: 3.205

3.  Optimizing an ultrafast generic high-performance liquid chromatography/tandem mass spectrometry method for faster discovery pharmacokinetic sample throughput.

Authors:  Kimberly W Dunn-Meynell; Samuel Wainhaus; Walter A Korfmacher
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

4.  Increase of the LC-MS/MS sensitivity and detection limits using on-line sample preparation with large volume plasma injection.

Authors:  Ming Li; Yazen Alnouti; Rachael Leverence; Honggang Bi; Arkady I Gusev
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-06-03       Impact factor: 3.205

5.  Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats.

Authors:  Kelly A Byrnes-Blake; Elizabeth M Laurenzana; Reid D Landes; W Brooks Gentry; S Michael Owens
Journal:  Eur J Pharmacol       Date:  2005-09-21       Impact factor: 4.432

6.  Two fatal intoxication cases with imidacloprid: LC/MS analysis.

Authors:  Paula Proença; Helena Teixeira; Fernando Castanheira; João Pinheiro; Paula V Monsanto; Estela P Marques; Duarte Nuno Vieira
Journal:  Forensic Sci Int       Date:  2005-10-04       Impact factor: 2.395

7.  Development of a high-throughput method for the determination of itraconazole and its hydroxy metabolite in human plasma, employing automated liquid-liquid extraction based on 96-well format plates and LC/MS/MS.

Authors:  Constantinos Kousoulos; Georgia Tsatsou; Constantinos Apostolou; Yannis Dotsikas; Yannis L Loukas
Journal:  Anal Bioanal Chem       Date:  2005-12-07       Impact factor: 4.142

8.  Determination of adefovir in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study.

Authors:  Hui-Chang Bi; Guo-Ping Zhong; Shufeng Zhou; Xiao Chen; Min Huang
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

9.  Application of direct urine LC-MS-MS analysis for screening of novel substances in drug abusers.

Authors:  Helena K Nordgren; Per Holmgren; Paula Liljeberg; Nadja Eriksson; Olof Beck
Journal:  J Anal Toxicol       Date:  2005 May-Jun       Impact factor: 3.367

Review 10.  Immunotherapy for the treatment of drug abuse.

Authors:  Thomas Kosten; S Michael Owens
Journal:  Pharmacol Ther       Date:  2005-10       Impact factor: 12.310

View more
  17 in total

1.  Gestation time-dependent pharmacokinetics of intravenous (+)-methamphetamine in rats.

Authors:  Sarah White; Elizabeth Laurenzana; Howard Hendrickson; W Brooks Gentry; S Michael Owens
Journal:  Drug Metab Dispos       Date:  2011-06-01       Impact factor: 3.922

2.  Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody Response.

Authors:  Michael D Hambuchen; F Ivy Carroll; Daniela Rüedi-Bettschen; Howard P Hendrickson; Leah J Hennings; Bruce E Blough; Lawrence E Brieaddy; Ramakrishna R Pidaparthi; S Michael Owens
Journal:  J Med Chem       Date:  2015-05-22       Impact factor: 7.446

3.  Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food.

Authors:  Daniela Rüedi-Bettschen; Sherri L Wood; Melinda G Gunnell; C Michael West; Rama R Pidaparthi; F Ivy Carroll; Bruce E Blough; S Michael Owens
Journal:  Vaccine       Date:  2013-07-29       Impact factor: 3.641

4.  The fate and function of therapeutic antiaddiction monoclonal antibodies across the reproductive cycle of rats.

Authors:  Jonathan J Hubbard; Elizabeth M Laurenzana; D Keith Williams; W Brooks Gentry; S Michael Owens
Journal:  J Pharmacol Exp Ther       Date:  2010-10-20       Impact factor: 4.030

5.  Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats.

Authors:  M L Miller; S M Aarde; A Y Moreno; K M Creehan; K D Janda; M A Taffe
Journal:  Drug Alcohol Depend       Date:  2015-06-19       Impact factor: 4.492

Review 6.  Monoclonal antibodies as pharmacokinetic antagonists for the treatment of (+)-methamphetamine addiction.

Authors:  S Michael Owens; William T Atchley; Michael D Hambuchen; Eric C Peterson; W Brooks Gentry
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

7.  A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats.

Authors:  Michelle L Miller; Amira Y Moreno; Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Brittani D Vaillancourt; M Jerry Wright; Kim D Janda; Michael A Taffe
Journal:  Biol Psychiatry       Date:  2012-10-23       Impact factor: 13.382

8.  Bioavailability of (+)-methamphetamine in the pigeon following an intramuscular dose.

Authors:  Howard P Hendrickson; William C Hardwick; D E McMillan; S Michael Owens
Journal:  Pharmacol Biochem Behav       Date:  2008-03-29       Impact factor: 3.533

9.  Maternal high fat diet during the perinatal period alters mesocorticolimbic dopamine in the adult rat offspring: reduction in the behavioral responses to repeated amphetamine administration.

Authors:  Lindsay Naef; Lalit Srivastava; Alain Gratton; Howard Hendrickson; S Michael Owens; Claire-Dominique Walker
Journal:  Psychopharmacology (Berl)       Date:  2007-11-16       Impact factor: 4.530

10.  Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats.

Authors:  Elizabeth M Laurenzana; Howard P Hendrickson; Dylan Carpenter; Eric C Peterson; W Brooks Gentry; Michael West; Yingni Che; F Ivy Carroll; S Michael Owens
Journal:  Vaccine       Date:  2009-10-01       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.